Adnan Elhammali

Adnan Elhammali practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Adnan Elhammali's NPI, 1366823064, was assigned on June 18, 2015. Adnan Elhammali holds Georgia license 86243.

Adnan Elhammali's primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Adnan Elhammali's primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. Adnan Elhammali is also affiliated with Northeast Georgia Medical Center Barrow. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology.

Dmand AI tracks the electronic health record (EHR) system at each site where Adnan Elhammali practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Adnan Elhammali's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Adnan Elhammali's licenses on file in 2 states: Georgia and Missouri.

CMS data shows 3,275 Medicare services from Adnan Elhammali across 22 procedure codes in 2024, for 291 Medicare patients. Medicare paid $232,634 for them. Every service was in an office.

CMS counts 291 Medicare patients who saw Adnan Elhammali in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adnan Elhammali's median patient age at 75, with 33% women.

In 2024, Adnan Elhammali wrote 424 Medicare Part D claims for 132 patients. 80% of them were for generic drugs. CMS names the drug for 339 of them, across 11 drugs with 11 or more claims each, at $174,652 in total drug cost. In 2023, CMS named 214 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Adnan Elhammali for performance year 2024, reported as part of a group. Adnan Elhammali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Adnan Elhammali as offering telehealth.

CMS Open Payments shows 36 general payments to Adnan Elhammali from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. GT Medical Technologies, Inc paid the most, $262.